CytoDyn Inc. Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
CytoDyn Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • CytoDyn Inc. Income Tax Expense (Benefit) for the quarter ending February 28, 2025 was $0.000.
  • CytoDyn Inc. Income Tax Expense (Benefit) for the twelve months ending February 28, 2025 was $0.000.
  • CytoDyn Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • CytoDyn Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • CytoDyn Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jun 1, 2023 May 31, 2024 10-K 2024-08-15
2022 $0 $0 Jun 1, 2022 May 31, 2023 10-K 2024-08-15
2021 $0 $0 Jun 1, 2021 May 31, 2022 10-K 2023-09-14
2020 $0 $0 Jun 1, 2020 May 31, 2021 10-K 2022-08-15
2019 $0 +$2.83M Jun 1, 2019 May 31, 2020 10-K 2022-08-15
2018 -$2.83M -$2.83M Jun 1, 2018 May 31, 2019 10-Q 2022-01-10
2017 $0 $0 Jun 1, 2017 May 31, 2018 10-K 2020-08-14
2016 $0 $0 Jun 1, 2016 May 31, 2017 10-K 2019-08-14
2015 $0 $0 Jun 1, 2015 May 31, 2016 10-K 2018-07-27
2014 $0 $0 Jun 1, 2014 May 31, 2015 10-K 2016-07-19
2013 $0 Jun 1, 2013 May 31, 2014 10-K 2015-07-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.